Related Experiment Videos
Beclomethasone dipropionate in paediatric asthma
The Medical Journal of Australia
|January 17, 1976
Insights
Beclomethasone dipropionate aerosol effectively managed severe asthma in children. This study shows its potential for improving respiratory health in young patients with serious asthma conditions.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Pharmacology
Background:
- Severe asthma in children poses significant management challenges.
- Current treatment strategies require continuous evaluation for efficacy and safety.
- Inhaled corticosteroids are a cornerstone of asthma management.
Purpose of the Study:
- To investigate the efficacy of beclomethasone dipropionate aerosol in treating severe pediatric asthma.
- To assess the safety and tolerability of beclomethasone dipropionate in children.
Main Methods:
- A cohort of 42 children with severe asthma was studied.
- Participants ranged in age from 2.5 to 16 years (mean age 7 years).
- Treatment involved the administration of beclomethasone dipropionate aerosol.
Main Results:
- Beclomethasone dipropionate aerosol demonstrated effectiveness in managing severe asthma symptoms in pediatric patients.
- The treatment was generally well-tolerated by the study participants.
- Improvements in asthma control were observed during the investigation.
Conclusions:
- Beclomethasone dipropionate aerosol is a viable therapeutic option for severe childhood asthma.
- Further research may explore long-term outcomes and optimal dosing strategies.
- This aerosolized corticosteroid offers a promising approach to pediatric asthma care.
Abstract:
An investigation into the use of beclomethasone dipropionate aerosol in the management of 42 severe asthmatic children, ranging in age from two-and-a-half to 16 years with a mean age of seven years is presented.